RGS
Click for more information
0.00% 12.0¢ regeneus ltd

Ann: Positive clinical trial results for Progenza, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. phillip_k
    4,884 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    22/05/17
    12:42
    Post #: 24833331
    As far as I am aware Mesoblast is the only stem cell ASX listed company that has moved beyond phase 1 trials. It is looking like RGS will be moving into phase 2 trial in Japan.
    RGS Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.